Plus, new coronavirus cases hit a record again, Amazon is acquiring self-driving start-up Yoox, Microsoft is permanently closing its retail locations, and Virgin Galactic successfully completed an important test.
Read MoreBuy Price: $47.50 or better Sell Price: TradersPro Sell Signal Natera, Inc. provides preconception and prenatal genetic testing services. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to […]
Read MorePlus, bank stocks are on the rise on reports of a change to the Volker Rule, the U.S. saw a record number of new coronavirus cases, last week’s jobless claims came in higher than expected, and Wirecard shares tanked after the troubled fintech filed for insolvency.
Read MoreBuy Price: $4.00 or better Sell Price: TradersPro Sell Signal Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform. Its platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then […]
Read MoreBuy Price: $6.25 or better Sell Price: TradersPro Sell Signal IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, which is in Phase IIb clinical trials for the treatment of geographic […]
Read MorePlus, stocks are up after President Trump said the U.S.-China phase one trade deal is still “fully intact” after confusion following a statement from trade advisor Peter Navarro, six global investors inked a $20.7 billion agreement with the Abu Dhabi National Oil Company, and Wirecard’s former CEO has been arrested.
Read MoreBuy Price: $4.25 or better Sell Price: TradersPro Sell Signal Agenus Inc., a clinical-stage immuno-oncology company, engages in advancing a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; and display […]
Read MorePlus, Gilead is gearing up to test an inhaled version of its antiviral drug remdesivir in the treatment of COVID-19, Microsoft is acquiring a cybersecurity startup, and Wirecard shares tanked after it said the $2.1 billion missing from its balance sheet likely doesn’t exist.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreThese 9 stocks have exploded higher since the market bottom.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases.
Read MorePlus, former FDA Commissioner Dr. Scott Gottlieb said states seeing surges of new coronavirus cases are “on the cusp of losing control” of their outbreaks, Wirecard shares are down after the German payments company said auditors couldn’t confirm the existence of $2.1 billion of cash on its balance sheet, and Spotify shares are up after it inks another big podcast deal.
Read MorePlus, Senate Republicans introduced their police reform bill with key differences from Democrats’ bill introduced last week, PepsiCo said its Aunt Jemima line is getting a rebrand, and Beyond Meat shares are up after Credit Suisse boosted their price target on the alternative meat stock.
Read MoreTrade Setup Buy Target $18.05 Sell Target $19.54 Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells.
Read MorePlus, retail sales jumped a record 17.7% in May, a sturdy from the University of Oxford showed a common anti-inflammatory drug proves to save lives among those sickest with COVID-19, and McDonald’s shares are slightly higher on improved sales in May.
Read More